Key Metrics
12.5
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
0.01 - 0.05
Eigenfactor
Eigenfactor
Eigenfactor Score measures the number of times articles from the journal published in the past five years have been cited. This does not include self citations.
5 - 10
Impact Factor
Impact Factor
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
92
H index
H-Index
Journal's h-index reflects the collective citation impact of the authors publishing in the journal. The h-index is defined as the maximum value of h such that the given journal has published at least h papers that have each been cited at least h times.
0.91
5-Year SI
5-year SI
- N/A 2-year SI
- 0.82 Lifetime SI
Scite Index
Scite Index
scite Index is the ratio of citations supporting research which is published in the journal to sum of citations either supporting or contrasting the research published in the journal for the same time period. Minimum 100 supporting citations required.
Q1
Oncology
SJR
- Q1 Oncology
- Q1 Cancer Research
- Q1 Gastroenterology
- Q1 Medicine (miscellaneous)
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
2.54
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
4 Mo
Time to Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Topics Covered
- Early Gastric Cancer
- Endoscopic submucosal dissection
- Lymph node
- Assay
- Advanced gastric cancer
- Observational study
- Gene expression
- Antibody response
- Overall survival
- Esophagogastric cancer
- Ramucirumab
- Lipid peroxidation
- Distal gastrectomy
- Lymph node metastasis
- Confidence interval
- Placebo
- Trastuzumab
- Quality of life
- Immunohistochemistry
- Cisplatin
Journal Specifications
| Overview | |
| Publisher | SPRINGER |
| Language | English |
| Frequency | Quarterly |
| General Details | |
| Language | English |
| Frequency | Quarterly |
| Publication Start Year | 1998 |
| Publisher URL | Visit website |
| Website URL | Visit website |
Planning to publish in Gastric Cancer ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Correction: Ubiquitous mitochondrial creatine kinase promotes the progression of gastric cancer through a JNK-MAPK/JUN/HK2 axis regulated glycolysis
- 22 Mar 24
- Gastric Cancer
-
Full paper
Perioperative chemotherapy with docetaxel plus oxaliplatin and S-1 (DOS) versus oxaliplatin plus S-1 (SOX) for the treatment of locally advanced gastric or gastro-esophageal junction adenocarcinoma (MATCH): an open-label, randomized, phase 2 clinical trial
- 8 Mar 24
- Gastric Cancer
-
Full paper
Dietary intake of vitamin C and gastric cancer: a pooled analysis within the Stomach cancer Pooling (StoP) Project
- 4 Mar 24
- Gastric Cancer
-
Full paper
Clinical practice guidelines for esophagogastric junction cancer: Upper GI Oncology Summit 2023
- 22 Feb 24
- Gastric Cancer
-
Full paper
Elucidating molecular mechanisms and therapeutic synergy: irreversible HER2-TKI plus T-Dxd for enhanced anti-HER2 treatment of gastric cancer
- 22 Feb 24
- Gastric Cancer
-
Full paper
Rivoceranib, a VEGFR-2 inhibitor, monotherapy in previously treated patients with advanced or metastatic gastric or gastroesophageal junction cancer (ANGEL study): an international, randomized, placebo-controlled, phase 3 trial
- 28 Jan 24
- Gastric Cancer
Scite analysis
Powered by scite_
2.1k articles received 59.6k citations see all
- 2,472 Supporting
- 55,378 Mentioning
- 524 Contrasting
Editorial notices
- 0 Retractions
- 0 Withdrawals
- 38 Corrections
- 39 Errata
- 0 Expression of Concern
Time To Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
% of papers by time taken from submission to publication
0 to 3 months
32%
4 to 6 months
56%
7 to 9 months
10%
Above 9 months
3%
Did you find this useful?
Thank you for your feedback.
FAQs
How long has Gastric Cancer been actively publishing?
Gastric Cancer has been in operation since 1998 till date.
What is the publishing frequency of Gastric Cancer ?
Gastric Cancer published with a Quarterly frequency.
How many articles did Gastric Cancer publish last years ?
In 2023, Gastric Cancer published 30 articles.
What is the eISSN & pISSN for Gastric Cancer ?
For Gastric Cancer,eISSN is 1436-3305 and pISSN is1436-3291.
What is Citescore for Gastric Cancer ?
Citescore for Gastric Cancer is 12.5.
What is H index for Gastric Cancer ?
H index for Gastric Cancer is 92.
What is SNIP score for Gastric Cancer ?
SNIP score for Gastric Cancer is 2.54.
What is the SJR for Gastric Cancer ?
SJR for Gastric Cancer is Q1.
Who is the publisher of Gastric Cancer ?
SPRINGER is the publisher of Gastric Cancer.